C-X-C ligand 13 (CXCL13), a regulator of mucosal immunity, is secreted by human endometrial epithelium and may be involved in embryo implantation. However, cyclic expression of human endometrial CXCL13 in health and disease is not well studied. This study examines cycle stage-specific endometrial CXCL13 expression in normal humans when compared to those with biopsy-confirmed, stage 1 to 4 endometriosis using real-time reverse transcriptase, real-time polymerase chain reaction and immunohistochemistry. Eutopic endometrial CXCL13 expression was also compared between normal, control Rhesus macaques, and macaques with advanced endometriosis. In healthy women, CXLC13 messenger RNA expression was minimal in the proliferative phase and maximal in the secretory phase. However, in the presence of endometriosis, proliferative-phase endometrial expression markedly increased in both humans and rhesus subjects (P < .05). The cross-species and cross-stage concordance suggests a pathophysiologic role for CXCL13 in endometriosis and its use as a biomarker for disease.
D’HoogheTMDebrockSHillJAMeulemanC. Endometriosis and subfertility: is the relationship resolved?Semin Reprod Med. 2003;21
(2):243–254.
2.
GallePC. Clinical presentation and diagnosis of endometriosis. Obstet Gynecol Clin North Am. 1989;16
(1):29–42.
3.
RawsonJM. Prevalence of endometriosis in asymptomatic women. J Reprod Med. 1991;36
(7):513–515.
4.
Endometriosis and infertility: a committee opinion. Fertil Steril. 2012;98(3):591–598.
5.
ChandALMurrayASJonesRLHannanNJSalamonsenLARombautsL. Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis. Reprod Biol Endocrinol. 2007;5:18.
6.
UlukusECUlukusMSevalYZhengWAriciA. Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis. Hum Reprod. 2005;20
(10):2958–2963.
7.
BulunSEChengYHYinP. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006;248
(1-2):94–103.
8.
KitawakiJKusukiIKoshibaHTsukamotoKHonjoH. Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Gynecol Obstet Invest. 1999;48(suppl 1):21–28.
9.
LesseyBACastelbaumAJSawinSW. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab. 1994;79
(2):643–649.
KennedySBergqvistAChapronC. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20
(10):2698–2704.
13.
BennettGLSlywotzkyCMCanteraMHechtEM. Unusual manifestations and complications of endometriosis--spectrum of imaging findings: pictorial review. AJR Am J Roentgenol. 2010;194(6 suppl):WS34–WS46.
14.
ChengYMWangSTChouCY. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol. 2002;99
(3):375–380.
15.
MolBWBayramNLijmerJG. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril. 1998;70
(6):1101–1108.
16.
HalmeJHammondMGHulkaJFRajSGTalbertLM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 1984;64
(2):151–154.
17.
DmowskiWPGebelHMBraunDP. The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand Suppl. 1994;159:7–14.
18.
EysterKMKlinkovaOKennedyVHansenKA. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril. 2007;88
(6):1505–1533.
19.
HaradaTIwabeTTerakawaN. Role of cytokines in endometriosis. Fertil Steril. 2001;76
(1):1–10.
20.
OosterlynckDJCornillieFJWaerMVandeputteMKoninckxPR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 1991;56
(1):45–51.
21.
SteeleRWDmowskiWPMarmerDJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol. 1984;6
(1):33–36.
22.
WitzCA. Interleukin-6: another piece of the endometriosis-cytokine puzzle. Fertil Steril. 2000;73
(2):212–214.
23.
BoddekeEW. Involvement of chemokines in pain. Eur J Pharmacol. 2001;429
(1-3):115–119.
24.
LebovicDIMuellerMDTaylorRN. Immunobiology of endometriosis. Fertil Steril. 2001;75
(1):1–10.
25.
FernandisAZPrasadABandHKloselRGanjuRK. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene. 2004;23
(1):157–167.
26.
ScottonCJWilsonJLScottK. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 2002;62
(20):5930–5938.
27.
BarczEKaminskiPMarianowskiL. Role of cytokines in pathogenesis of endometriosis. Med Sci Monit. 2000;6
(5):1042–1046.
28.
Garcia-VelascoJAAriciA. Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin. Fertil Steril. 1999;72
(2):336–340.
29.
AnselKMHarrisRBCysterJG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity. 2002;16
(1):67–76.
30.
DominguezFMartinezSQuinoneroA. CXCL10 and IL-6 induce chemotaxis in human trophoblast cell lines. Mol Hum Reprod. 2008;14
(7):423–430.
31.
MullerGHopkenUESteinHLippM. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol. 2002;72
(1):1–8.
32.
DominguezFGadeaBEstebanFJHorcajadasJAPellicerASimonC. Comparative protein-profile analysis of implanted versus non-implanted human blastocysts. Hum Reprod. 2008;23
(9):1993–2000.
33.
MacklonNSvan der GaastMHHamiltonAFauserBCGiudiceLC. The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci. 2008;15
(4):357–365.
34.
TalbiSHamiltonAEVoKC. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006;147
(3):1097–1121.
35.
BurneyROTalbiSHamiltonAE. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148
(8):3814–3826.
PetraccoRGKongAGrechukhinaOKrikunGTaylorHS. Global gene expression profiling of proliferative phase endometrium reveals distinct functional subdivisions. Reprod Sci. 2012;19
(10):1138–1145.
38.
HoustonDENollerKLMeltonLJIIISelwynBJHardyRJ. Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979. Am J Epidemiol. 1987;125
(6):959–969.
39.
BrennerRMSlaydenOD. Steroid receptors in blood vessels of the rhesus macaque endometrium: a review. Arch Histol Cytol. 2004;67
(5):411–416.
40.
SlaydenODBrennerRM. Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists. Arch Histol Cytol. 2004;67
(5):393–409.
41.
KeatorCSMahKOhmLSlaydenOD. Estrogen and progesterone regulate expression of the endothelins in the rhesus macaque endometrium. Hum Reprod. 2011;26
(7):1715–1728.
42.
PrittsEAAtwoodAK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod. 2002;17
(9):2287–2299.
KaoLCGermeyerATulacS. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003;144
(7):2870–2881.
45.
TaylorHSBagotCKardanaAOliveDAriciA. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod. 1999;14
(5):1328–1331.
46.
LeglerDFLoetscherMRoosRSClark-LewisIBaggioliniMMoserB. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 1998;187
(4):655–660.
47.
PaolettiSPetkovicVSebastianiSDanelonMGUguccioniMGerberBO. A rich chemokine environment strongly enhances leukocyte migration and activities. Blood. 2005;105
(9):3405–3412.
48.
KowarikMCCepokSSellnerJ. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J Neuroinflammation. 2012;9:93.
49.
VermiWLonardiSBosisioD. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. J Pathol. 2008;216
(3):356–364.
50.
IshikawaSMatsushimaK. Aberrant B1 cell trafficking in a murine model for lupus. Front Biosci. 2007;12:1790–1803.
51.
WongCKWongPTTamLSLiEKChenDPLamCW. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol. 2010;30
(1):45–52.
52.
FestaEDHankiewiczKKimS. Serum levels of CXCL13 are elevated in active multiple sclerosis. Mult Scler. 2009;15
(11):1271–1279.
53.
MeraounaACizeron-ClairacGPanseRL. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood. 2006;108
(2):432–440.
54.
CarlsenHSBaekkevoldESMortonHCHaraldsenGBrandtzaegP. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood. 2004;104
(10):3021–3027.
55.
MeeuwisseCMvan der LindenMPRullmannTA. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint. Arthritis Rheum. 2011;63(5):1265–1273.
56.
RiojaIHughesFJSharpCH. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Arthritis Rheum. 2008;58
(8):2257–2267.
57.
BiancoBAndreGMVilarinoFL. The possible role of genetic variants in autoimmune-related genes in the development of endometriosis. Hum Immunol. 2012;73
(3):306–315.
58.
OlovssonM. Immunological aspects of endometriosis: an update. Am J Reprod Immunol. 2011;66(suppl 1):101–104.
KhanKNKitajimaMHirakiK. Immunopathogenesis of pelvic endometriosis: role of hepatocyte growth factor, macrophages and ovarian steroids. Am J Reprod Immunol. 2008;60
(5):383–404.
61.
SinghSSinghRSharmaPK. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett. 2009;283
(1):29–35.
62.
El HaibiCPSharmaPKSinghR. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells. Mol Cancer. 2010;9:85.
63.
PanseJFriedrichsKMarxA. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. Br J Cancer. 2008;99
(6):930–938.
64.
WeissNDebouxCChaverotN. IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells. J Neuroimmunol. 2010;223
(1-2):131–134.
65.
LouboutinJPChekmasovaAMarusichEAgrawalLStrayerDS. Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB J. 2011;25
(2):737–753.
